# Cardinal Health (CAH.US)

Canonical: https://gigainvestors.com/s/CAH

Analysis as of: 2026-10-16T07:27:12.876Z. Financial observations: FY1997–FY2026.

Listing currency: USD. Reporting currency: USD.

## Verdict

Not a wonderful business

Quality tests for Buy: not passed (profit record: pass; earnings resilience is evidence only). Published buy qualification: no.

Share price: $253.71 per share; close as of 2026-10-15.

Estimated value: low $55.61 per share, central $63.27 per share, high $73.48 per share. Buy at or below the central value $63.27 per share. Valuation as of 2026-10-16T07:27:12.876Z; scenarios are not confidence intervals.

Expected annual return: 4.7% at the stated quote. About 4.7% a year at today's price (required return 10.0%). required return 10.0% a year (10% floor; US 10-year bond 5.1% + 4 points).

## Checklist

### understandable: fail

- 1 revenue decline in the last 10 years (informational)

- operating margin variation exceeds 0.35

- Financial history: 10 years

- Years with declining revenue: 1

- Years with a net loss: 2

- Operating margin variation: 3.43×

Chart: Operating margin; fiscal year observations.

- FY2017: 0.02×

- FY2018: 0.00×

- FY2019: 0.01×

- FY2020: -0.03×

- FY2021: 0.00×

- FY2022: -0.00×

- FY2023: 0.00×

- FY2024: 0.01×

- FY2025: 0.01×

- FY2026: 0.01×

### moat: fail

- Years with nonpositive invested capital use equity plus debt and leases; positive earnings with no positive capital are shown above 100%.

- ROIC worst years below threshold (more than 1 bad year allowed)

- ROIC, median of available years: 24.0%

- ROIC, second-lowest year: -9.4%

- Typical minus recent gross margin: 0.3 pp

- Typical gross margin (annual median): 4.0%

- Recent gross margin (lower of latest and 3-year median): 3.7%

- Years with nonpositive capital: 7

- Capital spending / revenue: 0.2%

- ROIC including acquisitions, ten-year median: 13.3%

Chart: ROIC excluding acquisitions; fiscal year observations.

- FY2017: 45.9%

- FY2018: 2.0%

- FY2019: 46.5%

- FY2020: -37.8%

- FY2021: 5.5%

- FY2022: -9.4%

- FY2023: 22.0%

- FY2024: 36.8%

- FY2025: 25.9%

- FY2026: 29.0%

### economics: pass

- Owner earnings / net income, 5-yr: 1.36×

- Cash conversion uses consolidated totals: No

- Owner earnings, five-year total: $4.8B

- Net income, five-year total: $3.5B

- Return on incremental invested capital: >100%

- Working capital / revenue, annual change: -0.4 pp

- Working capital / revenue, change between three-year averages: -2.7 pp

- Working capital / revenue, final three-year average: -2.3%

Chart: Annual owner cash / profit; fiscal year observations.

- FY2022: 0.67×

- FY2023: 1.64×

- FY2024: 1.23×

- FY2025: 1.16×

- FY2026: 1.18×

### management: pass

- Historical market-dollar context (not the management verdict): 2017 to 2026 (9 years)

- buybacks unrelated to price (informational)

- ROIC first 3 years vs last 3 years: 45.9% vs 29.0%

- Per-share earnings: 4.03 to 6.45 (three-year endpoint medians)

- Management verdict uses per-share economic progress: Yes

- Ordinary dilution, 10-year annual growth: -3.3%

- Ordinary dilution, 5-year annual growth: -4.2%

- Market cap gain: $31B

- Cumulative retained earnings: -$3.0B

- Diluted shares, 10-year annual growth: -3.3%

- Diluted shares, 5-year annual growth: -4.2%

- $1 test, starting fiscal year: FY2017

- $1 test, ending fiscal year: FY2026

- Per-share value growth: 6.1%

- Per-share value change: $2.43

- Per-share value, starting three-year median: $4.03

- Per-share value, ending three-year median: $6.45

- Buybacks concentrated in cheaper years (correlation): -0.28

- Average buyback yield: 3.6%

- Buyback history: 10 years

- Debt-funded buybacks: No

- Acquisition spending: $11B

- Cumulative net income, 10 years: $3.3B

- ROIC, first three-year median: 45.9%

- ROIC, last three-year median: 29.0%

Chart: Earnings per share; fiscal year observations.

- FY2017: $4.03

- FY2018: $0.81

- FY2019: $4.53

- FY2020: -$12.60

- FY2021: $2.08

- FY2022: -$3.36

- FY2023: $1.26

- FY2024: $3.45

- FY2025: $6.45

- FY2026: $7.23

### accounting: pass

- Sloan accruals: -6.0%

- Receivables to sales index (DSRI): 0.91×

- Restructuring years, last five: 2

- Stock compensation / operating cash flow: 7.1%

- Earnings backed by cash: Yes

- Operating cash / earnings: 3.02×

- Accounting red flags: 0

Chart: Sloan accruals; fiscal year observations.

- FY2017: 0.3%

- FY2018: -6.3%

- FY2019: -3.3%

- FY2020: -13.9%

- FY2021: -4.1%

- FY2022: -9.3%

- FY2023: -5.8%

- FY2024: -6.4%

- FY2025: -1.6%

- FY2026: -6.0%

## Holders

- [Mason Hawkins](https://gigainvestors.com/SE): tracked 13F investor; follow the investor page for holding quarter and amounts.

## Price story

Price needs cash profits to grow 18.6% a year for ten years · sales +14.2%

Story as of 2026-10-16T09:58:27.190Z; price observation 2026-10-15.

Price needs cash profits to grow 18.6% a year for ten years

- 2025-05-02: Cardinal Health Lifts FY25 EPS Outlook, Sees Growth Despite Tariff Risks ([finance.yahoo.com](https://finance.yahoo.com/news/cardinal-health-lifts-fy25-eps-043902914.html))

- 2025-06-12: Cardinal Health Raises Full-Year Earnings Outlook, Issues Upbeat Preliminary 2026 Profit Guidance ([finance.yahoo.com](https://finance.yahoo.com/news/cardinal-health-raises-full-earnings-142223902.html))

- 2025-10-30: CAH Q1 Earnings Beat Estimates, '26 EPS View Up, Stock Gains ([finance.yahoo.com](https://finance.yahoo.com/news/cah-q1-earnings-beat-estimates-142900344.html))

- 2026-02-05: Cardinal Health boosts annual profit forecast banking on surging demand for specialty drugs ([finance.yahoo.com](https://finance.yahoo.com/news/cardinal-health-boosts-annual-profit-125607323.html))

- 2026-04-30: Cardinal Health lifts annual profit forecast on strong demand for specialty drugs ([finance.yahoo.com](https://finance.yahoo.com/sectors/healthcare/articles/cardinal-health-lifts-annual-profit-111756708.html))

- 2026-10-01: Cardinal Health rises on extended CVS distribution deal ([finance.yahoo.com](https://finance.yahoo.com/healthcare/articles/cardinal-health-rises-extended-cvs-201217977.html))

### Sales · FY2025–2026

sales +14.2%; source https://www.sec.gov/Archives/edgar/data/721371/000072137126000038/cah-20260630.htm; observed 2026-08-11.

- FY2017: $130B 

- FY2018: $137B 

- FY2019: $146B 

- FY2020: $153B 

- FY2021: $162B 

- FY2022: $181B 

- FY2023: $205B 

- FY2024: $227B 

- FY2025: $223B 

- FY2026: $254B 

### Gross margin · FY2026

gross margin 3.8%; source https://www.sec.gov/Archives/edgar/data/721371/000072137126000038/cah-20260630.htm; observed 2026-08-11.

- FY2017: 5.0% 

- FY2018: 5.2% 

- FY2019: 4.7% 

- FY2020: 4.5% 

- FY2021: 4.2% 

- FY2022: 3.6% 

- FY2023: 3.4% 

- FY2024: 3.3% 

- FY2025: 3.7% 

- FY2026: 3.8% 

## Owner memo

Memo as of 2026-10-16T08:06:05.509Z.

### How it makes money

Operates in medical distribution; annual sales are USD 254.2 billion.

- Source: https://www.sec.gov/Archives/edgar/data/721371/000072137126000038/cah-20260630.htm (filed 2026-08-11); FY2026: revenue 254248000000; grossProfit 9774000000; margin = grossProfit / revenue.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-16); CAH.US: Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

### Why customers stay

Margins ranged from 3.3% to 3.8% during 2024–26; it earns 24% on its capital.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-08-11); FY2024: grossProfit / revenue = 3.3%.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-08-11); FY2025: grossProfit / revenue = 3.7%.

- Source: https://www.sec.gov/Archives/edgar/data/721371/000072137126000038/cah-20260630.htm (filed 2026-08-11); FY2026: grossProfit / revenue = 3.8%.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-08-11); 10-year return on capital observations [[2017,0.45949764931395615],[2018,0.019935910274384138],[2019,0.4654731457800511],[2020,-0.37802662307333024],[2021,0.05549024218198918],[2022,-0.09409929356357928],[2023,0.22037871956717764],[2024,0.36845999229912746],[2025,0.25882708416902545],[2026,0.29006283485390943]]; median 0.23960290186810154. ROIC follows the displayed moat series; financial companies use return on tangible equity.

### Can it raise prices

Kept about a 4% gross margin through 2022 cost inflation.

- Source: https://www.sec.gov/Archives/edgar/data/721371/000072137126000038/cah-20260630.htm (filed 2026-08-11); Gross margin observations: [[2021,0.04171924144595518],[2022,0.03575879906908],[2023,0.03360832085238]]; range within 2 percentage points.

### Where the cash goes

Paid dividends in 10 of 10 years; bought back USD 1.4 billion of shares.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-08-11); FY2017: growth capex 0; upkeep 387000000; owner earnings 1618000000. Growth capex / owner earnings = 0.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-08-11); FY2018: growth capex 0; upkeep 384000000; owner earnings 904000000. Growth capex / owner earnings = 0.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-08-11); FY2019: growth capex 0; upkeep 328000000; owner earnings 2035000000. Growth capex / owner earnings = 0.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-08-11); FY2021: growth capex 0; upkeep 400000000; owner earnings 994000000. Growth capex / owner earnings = 0.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-08-11); FY2023: growth capex 0; upkeep 481000000; owner earnings 541000000. Growth capex / owner earnings = 0.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-08-11); FY2024: growth capex 0; upkeep 511000000; owner earnings 1051000000. Growth capex / owner earnings = 0.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-08-11); FY2025: growth capex 0; upkeep 547000000; owner earnings 1804000000. Growth capex / owner earnings = 0.

- Source: https://www.sec.gov/Archives/edgar/data/721371/000072137126000038/cah-20260630.htm (filed 2026-08-11); FY2026: growth capex 0; upkeep 649000000; owner earnings 2021000000. Growth capex / owner earnings = 0.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-08-11); Dividend observations: [[2017,577000000],[2018,581000000],[2019,577000000],[2020,569000000],[2021,573000000],[2022,559000000],[2023,525000000],[2024,499000000],[2025,494000000],[2026,491000000]]. Zero only counted when supported by a complete cash-flow statement.

- Source: https://www.sec.gov/Archives/edgar/data/721371/000072137126000038/cah-20260630.htm (filed 2026-08-11); FY2026: cash repurchases 1358000000 USD.

### Are managers owners

Insiders own 0.3% of the company.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-16); CAH.US SharesStats.PercentInsiders = 0.281 percentage points; cache date 2026-10-16.

### What could break it

"Our sales and credit concentration is significant." (SEC filing, Aug 2026)

- Source: https://www.sec.gov/Archives/edgar/data/721371/000072137126000038/cah-20260630.htm (filed 2026-08-11); Our sales and credit concentration is significant.

### What the price says

The price assumes cash profits grow 18.6% yearly over ten years; actual growth was 5.8%.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-08-11); Ten-year compound average after fade. Initial solved rate 0.2566769242915662. Price 253.71; FX 1; discount 0.1; same standard ten-year fade to terminal 0.03. FY2016 owner earnings/share 4.857575757575757 → FY2026 8.527426160337553. Closing-price date 2026-10-15.

## Monthly share-price history (USD per share)

- 2016-10: $68.69 per share

- 2016-11: $71.01 per share

- 2016-12: $71.97 per share

- 2017-01: $74.96 per share

- 2017-02: $81.37 per share

- 2017-03: $81.55 per share

- 2017-04: $72.59 per share

- 2017-05: $74.29 per share

- 2017-06: $77.92 per share

- 2017-07: $77.26 per share

- 2017-08: $67.46 per share

- 2017-09: $66.92 per share

- 2017-10: $61.90 per share

- 2017-11: $59.19 per share

- 2017-12: $61.27 per share

- 2018-01: $71.79 per share

- 2018-02: $69.21 per share

- 2018-03: $62.68 per share

- 2018-04: $64.17 per share

- 2018-05: $52.09 per share

- 2018-06: $48.83 per share

- 2018-07: $49.95 per share

- 2018-08: $52.19 per share

- 2018-09: $54.00 per share

- 2018-10: $50.60 per share

- 2018-11: $54.83 per share

- 2018-12: $44.60 per share

- 2019-01: $49.97 per share

- 2019-02: $54.34 per share

- 2019-03: $48.15 per share

- 2019-04: $48.71 per share

- 2019-05: $42.07 per share

- 2019-06: $47.10 per share

- 2019-07: $45.73 per share

- 2019-08: $43.13 per share

- 2019-09: $47.19 per share

- 2019-10: $49.45 per share

- 2019-11: $55.03 per share

- 2019-12: $50.58 per share

- 2020-01: $51.21 per share

- 2020-02: $52.12 per share

- 2020-03: $47.94 per share

- 2020-04: $49.48 per share

- 2020-05: $54.69 per share

- 2020-06: $52.19 per share

- 2020-07: $54.62 per share

- 2020-08: $50.76 per share

- 2020-09: $46.95 per share

- 2020-10: $45.79 per share

- 2020-11: $54.59 per share

- 2020-12: $53.56 per share

- 2021-01: $53.73 per share

- 2021-02: $51.52 per share

- 2021-03: $60.75 per share

- 2021-04: $60.34 per share

- 2021-05: $56.07 per share

- 2021-06: $57.09 per share

- 2021-07: $59.38 per share

- 2021-08: $52.49 per share

- 2021-09: $49.46 per share

- 2021-10: $47.81 per share

- 2021-11: $46.23 per share

- 2021-12: $51.49 per share

- 2022-01: $51.57 per share

- 2022-02: $54.01 per share

- 2022-03: $56.70 per share

- 2022-04: $58.05 per share

- 2022-05: $56.32 per share

- 2022-06: $52.27 per share

- 2022-07: $59.56 per share

- 2022-08: $70.72 per share

- 2022-09: $66.68 per share

- 2022-10: $75.90 per share

- 2022-11: $80.17 per share

- 2022-12: $76.87 per share

- 2023-01: $77.25 per share

- 2023-02: $75.71 per share

- 2023-03: $75.50 per share

- 2023-04: $82.10 per share

- 2023-05: $82.30 per share

- 2023-06: $94.57 per share

- 2023-07: $91.47 per share

- 2023-08: $87.33 per share

- 2023-09: $86.82 per share

- 2023-10: $91.00 per share

- 2023-11: $107.08 per share

- 2023-12: $100.80 per share

- 2024-01: $109.19 per share

- 2024-02: $111.98 per share

- 2024-03: $111.90 per share

- 2024-04: $103.04 per share

- 2024-05: $99.27 per share

- 2024-06: $98.32 per share

- 2024-07: $100.83 per share

- 2024-08: $112.72 per share

- 2024-09: $110.52 per share

- 2024-10: $108.52 per share

- 2024-11: $122.24 per share

- 2024-12: $118.27 per share

- 2025-01: $123.66 per share

- 2025-02: $129.48 per share

- 2025-03: $137.77 per share

- 2025-04: $141.29 per share

- 2025-05: $154.44 per share

- 2025-06: $168.00 per share

- 2025-07: $155.22 per share

- 2025-08: $148.78 per share

- 2025-09: $156.96 per share

- 2025-10: $190.77 per share

- 2025-11: $212.26 per share

- 2025-12: $205.50 per share

- 2026-01: $214.88 per share

- 2026-02: $229.23 per share

- 2026-03: $211.31 per share

- 2026-04: $192.88 per share

- 2026-05: $196.80 per share

- 2026-06: $237.56 per share

- 2026-07: $230.03 per share

- 2026-08: $234.62 per share

- 2026-09: $222.50 per share

- 2026-10: $239.72 per share

## Annual estimated value (USD per share)

- FY2017: low $71.92 per share, central $80.00 per share, high $90.74 per share

- FY2018: low $62.61 per share, central $71.24 per share, high $82.73 per share

- FY2019: low $69.70 per share, central $79.31 per share, high $92.10 per share

- FY2020: low $71.01 per share, central $80.81 per share, high $93.84 per share

- FY2021: low $40.45 per share, central $45.95 per share, high $53.28 per share

- FY2022: low $43.46 per share, central $49.45 per share, high $57.43 per share

- FY2023: low $22.57 per share, central $25.68 per share, high $29.82 per share

- FY2024: low $26.49 per share, central $30.14 per share, high $35.01 per share

- FY2025: low $46.58 per share, central $53.00 per share, high $61.55 per share

- FY2026: low $54.33 per share, central $61.82 per share, high $71.79 per share

Historical values use today's bond yield for every fiscal year

Historical values use today's FX rate into trading currency for every fiscal year

Historical values use current restated fundamentals and current commodity classification; they are not point-in-time estimates

## Sources

[Original 10-K filing](https://www.sec.gov/Archives/edgar/data/721371/000072137126000038/cah-20260630.htm); period 2026-06-30, filed 2026-08-11.

Estimates depend on assumptions and are not guarantees or investment advice. Underlying data remains subject to its source licenses; public reading does not grant bulk redistribution rights.

## Reported holder observations

- [Mason Hawkins](https://gigainvestors.com/SE): 7,337 CAH shares; USD 1,743,000 reported position value; 0.09% of portfolio; hold; quarter 2026 Q2.

# CAH — Cardinal Health Inc.

Held by 1 investor · USD 1,743,000 total · 2026 Q2 · reported price USD 237.56 (split-adjusted).
Page: https://gigainvestors.com/s/CAH

## Holders (2026 Q2)

| Investor | Value | % of their portfolio | This quarter |
|---|---:|---:|---|
| Mason Hawkins (https://gigainvestors.com/SE) | USD 1,743,000 | 0.1% | hold |

## Total held by quarter

- 2008 Q1: USD 51,696,095 · 1 holder · USD 52.51
- 2008 Q2: USD 54,860,488 · 1 holder · USD 51.58
- 2008 Q3: USD 66,695,552 · 1 holder · USD 49.28
- 2008 Q4: USD 50,615,748 · 1 holder · USD 34.47
- 2009 Q1: USD 26,767,444 · 1 holder · USD 31.48
- 2009 Q2: USD 38,016,420 · 1 holder · USD 30.55
- 2009 Q3: USD 34,974,000 · 1 holder · USD 26.80
- 2009 Q4: USD 0 · 0 holders
- 2010 Q1: USD 0 · 0 holders
- 2010 Q2: USD 0 · 0 holders
- 2010 Q3: USD 0 · 0 holders
- 2010 Q4: USD 0 · 0 holders
- 2011 Q1: USD 0 · 0 holders
- 2011 Q2: USD 0 · 0 holders
- 2011 Q3: USD 0 · 0 holders
- 2011 Q4: USD 0 · 0 holders
- 2012 Q1: USD 0 · 0 holders
- 2012 Q2: USD 0 · 0 holders
- 2012 Q3: USD 37,259,217 · 1 holder · USD 38.97
- 2012 Q4: USD 37,313,198 · 1 holder · USD 41.18
- 2013 Q1: USD 55,378,115 · 2 holders · USD 41.62
- 2013 Q2: USD 53,128,131 · 2 holders · USD 47.20
- 2013 Q3: USD 47,779,830 · 1 holder · USD 52.15
- 2013 Q4: USD 46,566,570 · 1 holder · USD 66.81
- 2014 Q1: USD 43,926,446 · 1 holder · USD 69.98
- 2014 Q2: USD 0 · 0 holders
- 2014 Q3: USD 0 · 0 holders
- 2014 Q4: USD 0 · 0 holders
- 2015 Q1: USD 0 · 0 holders
- 2015 Q2: USD 0 · 0 holders
- 2015 Q3: USD 0 · 0 holders
- 2015 Q4: USD 0 · 0 holders
- 2016 Q1: USD 0 · 0 holders
- 2016 Q2: USD 0 · 0 holders
- 2016 Q3: USD 0 · 0 holders
- 2016 Q4: USD 74,129,100 · 1 holder · USD 71.97
- 2017 Q1: USD 83,996,500 · 1 holder · USD 81.55
- 2017 Q2: USD 158,177,600 · 1 holder · USD 77.92
- 2017 Q3: USD 169,307,600 · 1 holder · USD 66.92
- 2017 Q4: USD 312,477,000 · 1 holder · USD 61.27
- 2018 Q1: USD 319,668,000 · 1 holder · USD 62.68
- 2018 Q2: USD 249,033,000 · 1 holder · USD 48.83
- 2018 Q3: USD 255,878,190 · 1 holder · USD 54.00
- 2018 Q4: USD 65,457,279 · 1 holder · USD 44.60
- 2019 Q1: USD 0 · 0 holders
- 2019 Q2: USD 9,420,000 · 1 holder · USD 47.10
- 2019 Q3: USD 0 · 0 holders
- 2019 Q4: USD 0 · 0 holders
- 2020 Q1: USD 0 · 0 holders
- 2020 Q2: USD 0 · 0 holders
- 2020 Q3: USD 0 · 0 holders
- 2020 Q4: USD 0 · 0 holders
- 2021 Q1: USD 0 · 0 holders
- 2021 Q2: USD 0 · 0 holders
- 2021 Q3: USD 0 · 0 holders
- 2021 Q4: USD 0 · 0 holders
- 2022 Q1: USD 0 · 0 holders
- 2022 Q2: USD 25,459,933 · 1 holder · USD 52.27
- 2022 Q3: USD 23,731,412 · 1 holder · USD 66.68
- 2022 Q4: USD 18,032,933 · 1 holder · USD 76.87
- 2023 Q1: USD 77,047,826 · 1 holder · USD 75.50
- 2023 Q2: USD 57,391,790 · 1 holder · USD 94.57
- 2023 Q3: USD 66,446,298 · 1 holder · USD 86.82
- 2023 Q4: USD 57,226,176 · 1 holder · USD 100.80
- 2024 Q1: USD 61,637,896 · 2 holders · USD 111.90
- 2024 Q2: USD 67,579,916 · 2 holders · USD 98.34
- 2024 Q3: USD 63,106,257 · 2 holders · USD 110.52
- 2024 Q4: USD 2,078,953 · 1 holder · USD 118.25
- 2025 Q1: USD 2,421,959 · 1 holder · USD 137.76
- 2025 Q2: USD 1,787,979 · 1 holder · USD 167.98
- 2025 Q3: USD 1,671,002 · 1 holder · USD 156.99
- 2025 Q4: USD 1,777,024 · 1 holder · USD 205.46
- 2026 Q1: USD 1,550,015 · 1 holder · USD 211.26
- 2026 Q2: USD 1,743,000 · 1 holder · USD 237.56